Clinical Performance of a Delphi Consensus and the sFlt-1/PlGF-ratio in Guiding Delivery Decisions in Early-Onset Preeclampsia Before 32 Weeks
Geburtshilfe und Frauenheilkunde · 01.10.2026 · 86 (10) · 925-935
DOI: 10.1055/a-2902-9372 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.10.2026. Verfasst von Lisa Antonia Lorenz-Meyer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of ObstetricsCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu BerlinBerlinGerma…. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A recent Delphi consensus defined organ-system-based parameters intended to reflect disease severity and delivery urgency in preeclampsia (PE) ≤ 32 weeks. This study evaluates the applicability of these parameters in a real-world cohort. In a retrospective cohort of 1928 women with suspected PE, 148 presented at ≤ 32 weeks, of whom 84 (56.8%) delivered at ≤ 32 weeks. Delivery indications documented in medical records were compared with organ-based Delphi criteria, and Likert scores were calculated. The association between the Delphi Score and the risk of PE-related delivery, as well as Delphi organ-system scores, mean maximal arterial blood pressure and the sFlt-1/PlGF-ratio were examined using regression analysis. ROC analyses and likelihood ratio tests were used to assess the Delphi score, sFlt-1/PlGF-ratio, and the combination of both to predict PE-related delivery. The Delphi score was associated with an increased risk of PE-related deliveries ≤ 32+0 weeks (OR 1.27 per point, 95% CI 1.12–1.45), p < 0.001) but demonstrated limited predictive accuracy (AUC 0.699 (95% CI 0.612–0.787). Adding the sFlt-1/PlGF-ratio markedly improved model performance (χ2 from 16.3 to 72.4, p < 0.001; AUC 0.891, 95% CI 0.839–0.943). In the organ subscores, the uteroplacental and fetal Delphi criteria showed the strongest association (44% delivering ≤ 32 weeks vs. 9.4% delivering > 32 weeks). Severe hypertension (≥ 160/100 mmHg), not reflected in the Delphi criteria, led to 60.7% of deliveries. In this retrospective real-world cohort, the Delphi score showed limited applicability for guiding delivery decisions in PE ≤ 32 weeks. Incorporating broader hypertension thresholds and biomarkers may enhance decision-making approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of ObstetricsCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu BerlinBerlinGermany.
- Department of Obstetrics, Gynecology and Reproductive MedicineHannover Medical SchoolHannoverGermany.
- Department of Obstetrics and GynecologyUniversity Hospital WürzburgWürzburgGermany.
ORCID-Profile: Lars Brodowski
Zitieren
APA
Lorenz-Meyer, L. A., Scheele, C., Brodowski, L., Pecks, U., & Dressler-Steinbach, I. (2026). Clinical Performance of a Delphi Consensus and the sFlt-1/PlGF-ratio in Guiding Delivery Decisions in Early-Onset Preeclampsia Before 32 Weeks. Geburtshilfe und Frauenheilkunde, 86(10), 925-935. https://doi.org/10.1055/a-2902-9372
Vancouver
Lorenz-Meyer LA, Scheele C, Brodowski L, Pecks U, Dressler-Steinbach I. Clinical Performance of a Delphi Consensus and the sFlt-1/PlGF-ratio in Guiding Delivery Decisions in Early-Onset Preeclampsia Before 32 Weeks. Geburtshilfe und Frauenheilkunde. 2026;86(10):925-935. doi:10.1055/a-2902-9372
BibTeX
@article{LorenzMeyer2026,
author = {Lorenz-Meyer, Lisa Antonia and Scheele, Caroline and Brodowski, Lars and Pecks, Ulrich and Dressler-Steinbach, Iris},
title = {Clinical Performance of a Delphi Consensus and the sFlt-1/PlGF-ratio in Guiding Delivery Decisions in Early-Onset Preeclampsia Before 32 Weeks},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2026},
volume = {86},
number = {10},
pages = {925--935},
doi = {10.1055/a-2902-9372}
}
EUVIMED